School of Medicine - Faculty - English - 西湖大学展厅-WUEH4副屏

FACULTY

Faculty

At Westlake, we welcome talented people, outstanding scholars, research fellows, and young scientists from all backgrounds. We expect to have a community of 300 assistant, associate, and full professors (including chair professors), 600 research, teaching, technical support and administrative staff, and 900 postdoctoral fellows by 2026.

School of Medicine

The Westlake University School of Medicine aims to train top physician-scientists. It is committed to medical innovation and clinical transformation, focusing on microbiology and vaccines, immunology and inflammation, physiology and metabolism, tumor biology and treatment, medical genetics, rare diseases, drug research and development, public health, and other related research fields.

Top-notch physician-scientists are medical talents possessing solid basic medical knowledge and clinical diagnosis skills, who have received systematic training in biomedical research and can simultaneously apply the different methodologies of basic research and clinical treatment, the leading force that drives medical innovation.

Westlake University and the Hangzhou Municipal Health Commission signed the agreement to jointly build the Hangzhou First People's Hospital Affiliated to the Westlake University School of Medicine.

Establishing a new type of School of Medicine is an essential endeavor of Westlake University in response to the national and people's need for health and healthcare. It is vital to the university's strategy to expand its disciplinary development and talent recruitment. We will strive to build a new system of Westlake medical education and actively explore new ways to construct a research medical school, contributing the strength of Westlake to medical development in China and the world.

Dean

Chen Dong

Dean

Dr. Dong is a Chair Professor at Westlake University, where he also is Vice President and Dean of School of Medicine. Dr. Dong served as a Chair Professor of Immunology and the Director of the Center for inflammation and Cancer at the University of Texas MD Anderson Cancer Center before his move to China. He was Dean of Tsinghua University School of Medicine in 2016-2020 and Director of Institute of Immunology at Tsinghua University in 2014-2021, and Associate Vice President at Shanghai Jiao Tong University Schools in 2022-2023, and Director for the Shanghai Immune Therapy Institute from 2021.

Dr. Dong’s research is to understand the molecular mechanisms whereby immune and inflammatory responses are normally regulated, and to apply this knowledge to the understanding and treatment of infection, autoimmunity and allergy disorders as well as cancer. The work from Dr. Dong’s group has led to the discoveries of Th17 and T follicular helper (Tfh) cell subsets in the immune system and elucidation of their biological and pathological functions.

Dr. Dong has over 200 publications and was rated highly cited researcher for seven times. The honors he has received include the 2009 American Association of Immunologists-BD Bioscience Investigator Award, 2019 International Cytokine and Interferon Society Biolegend-William E. Paul Award, and 2024 Distinguished Fellow of American Association of Immunologists. He is a member of the Chinese Academy of Sciences and a fellow of the American Association for the advancement of Science and the Chinese Academy of Medicine. He is currently co-editor-in-chief for Current Opinion in Immunology and hLife, Editor-in-chief for Frontiers in Immunology- T Cell Biology, Executive Associate Editor for China Sciences- Life Sciences, Associate Editor for Advances in Immunology, and an Editor for Annual Review of Immunology Immunity, and Journal of Experimental Medicine, and a Scientific Advisor for Med.

View More Return

Faculty （Listed in alphabetical order by last name）

Affiliated Hospital

Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, is one of the first four hospitals in Zhejiang Province to pass the Triple-A accreditation, and one of the hospitals with the most complete clinical disciplines and strongest service capacity in Zhejiang Province, with the leading service capacity in general surgery, cardiovascular and metabolic diseases, gastroenterology, oncology, hematology and rare diseases, obstetrics and gynecology and pediatrics in China. As the first pilot hospital exploring group management and medical association construction in Zhejiang Province, it has 10 campuses with more than 6,000 open beds.

The hospital has a complete teaching and research system, and has research platforms such as National Postdoctoral Research Workstation, Key Laboratory of Clinic Cancer Pharmacy and Toxicology Research of Zhejiang Province, Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Zhejiang Key Laboratory of Molecular Tumor Combining Traditional Chinese and Western Medicine, Key Laboratory of Integrated Traditional Chinese and Western Medicine for Biliary and Pancreatic Diseases of Zhejiang Province,Zhejiang Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Senile Chronic Disease.The hospital boasts a pool of high-level talents, including Yangtze River Scholars, experts with the State Council Special Allowance, recipients of the National New Century Talents Program, experts who have been conferred with honorary titles such as Young Experts with Outstanding Contributions, National Outstanding Youth, Leading Talents of the National Ten Thousand Talents Program.As the first batch of national standardized training bases for residents, As the first batch of National Standardized Residency Training Bases for residents, the hospital has 21 certified subject bases, 24 teaching and research sections, more than 460 trained experts and teachers, and offers standardized residency training.